CKD Bio said it has confirmed the non-inferiority of CKDB-501A, aimed at improving moderate to severe frown lines, compared to Botox through a phase 3 clinical trial's topline results.The analysis of the data revealed that the improvement rate for frown lines when frowning was 80.69 percent (117 out
A new proposal for the expansion of medical school quotas by Professor Shin Young-seok of the Korea University Graduate School of Public Health, the principal researcher who previously provided the basis for the government's plan to increase the number of medical students by 2,000, is drawing signif
GC Cell said that its U.S. affiliate, Artiva Biotherapeutics, has received fast-track designation from the U.S. FDA for their investigational lupus nephritis treatment, AlloNK (development code name: AB-101).The fast track designation is intended to facilitate the development and expedite the review
The Korea Research-based Pharmaceutical Industry Association (KRPIA) announced that it has appointed Bae Kyung-eun, General Manager of Sanofi-Aventis Korea, as the 15th chairperson of the association.This decision was made during the association's board meeting, marking a new chapter in KRPIA's lead
Alteogen, a Kosdaq-listed biotech company, said it has made an amendment to its existing license agreement with the global pharmaceutical company MSD, known as Merck & Co. in the U.S. and Canada.The revised agreement grants MSD exclusive global rights to ALT-B4, a recombinant human hyaluronidase enz
Samsung Bioepis said it has made significant progress with its autoimmune disease treatment biosimilar, SB17, suggesting its potential use across all indications treatable by the original drug, Stelara.Stelara is an interleukin (IL)-12, 23 inhibitor developed by Janssen. It is used to treat inflamma
In a move to combat the rising threat of cardiovascular disease (CVD) in the Asia-Pacific region, Korea Biomedical Review (KBR) has announced its partnership with the APAC CVD Alliance on Thursday. Yang Kyung-cheol, CEO and publisher of KBR, and Dr. Krishna Reddy Nallamalla, CEO of ACCESS Health Int
As tensions between the U.S. and China in the healthcare industry escalate, the U.S. is intensifying its scrutiny of Chinese companies, extending beyond the biotech sector into medical devices.The U.S. FDA has recently issued a warning to medical device manufacturers to re-examine the work of third-
Korean medical experts have welcomed the introduction of Pfizer’s Zavicefta (ingredient: ceftazidime/avibactam), a new antibiotic treatment for infections caused by multi-drug resistant organisms, including carbapenem-resistant Enterobacteriaceae (CRE).During a press conference organized by Pfizer K
In the midst of a deepening dispute between the Korean government and medical professionals over medical school quotas, an unprecedented number of resident doctors and medical students are turning their attention to the United States Medical Licensing Examination (USMLE), signaling a potential mass
In what's quickly become the talk of the town—or rather, the chirp of the medical community—the Vice Minister of Health and Welfare Park Min-soo has ruffled more than a few feathers with a slip of the tongue that has doctors across the nation tweeting with outrage and bemusement.During a recent brie
MediThinQ, a company focusing on medical augmented reality (AR) technology, has announced a strategic partnership with Medtronic to introduce the AR wearable display, Scopeye, into the U.S. market.At a press conference on Wednesday, MediThinQ CEO Im Seung-joon detailed the collaboration's objectives
The Ministry of Food and Drug Safety announced a three-month manufacturing suspension for Celltrion Pharm's Astection Enteric Coated Tablets 100mg (aspirin), effective from Feb. 27 to May 26, due to violations of the Pharmaceutical Affairs Act.The medication is used for preventing thrombosis in cond
On Monday, trainee doctors at Korea’s so-called “Big 5” hospitals submitted a wave of resignations, despite the government’s threat to suspend their medical licenses if they do not return to work.The five largest hospitals are Seoul National University Hospital, Samsung Medical Center, Asan Medical
Seegene, once hailed as a beneficiary of the Covid-19 pandemic, has reported a significant deterioration in profitability due to a drastic decline in related sales as the world transitions to the endemic phase of the virus.The company announced its preliminary financial results for 2023 last Friday,
VUNO said it has entered into a strategic partnership with DRGEM to embed VUNO's advanced AI solutions into DRGEM's X-ray systems.Under the agreement, VUNO will supply its AI-based thoracic X-ray interpretation assistant solution, VUNOMED Chest X-ray, to DRGEM.VUNOMED Chest X-ray stands out as an AI
In recent years, Korea's market for pediatric growth hormone treatments has witnessed a significant surge, with non-reimbursable treatments accounting for 90 percent of the total prescriptions. According to IQVIA, a drug market research firm, the pediatric growth hormone treatment market grew to 238
A research team at Yongin Severance Hospital has demonstrated the effectiveness of ChatGPT, specifically the GPT-4 model, in accurately predicting cardiovascular diseases.GPT-4, the latest iteration of the ChatGPT series developed by OpenAI, has previously garnered attention for passing the United S
Daewoong Pharmaceutical's Fexuclue is expanding globally as fast as it is effective.Daewoong said Friday that its gastroesophageal reflux disease (GERD) treatment, Fexuclue, has entered or is about to enter the market in 24 countries, including Korea, in just one year and six months since its launch
Lunit announced a record-breaking revenue of 25 billion won ($21 million) for 2023, marking an 80.9 percent increase from 13.8 billion won a year earlier, thanks to a continued expansion of overseas sales of medical AI solutions. Last year, the Kosdaq-listed company posted an operating loss of appro